Suchergebnisse - "Schmid, Sebastian C"

PubPharm (4)

1

Chromogranin A and neurone-specific enolase serum levels as predictors of treatment outcome in patients with metastatic castration-resistant prostate cancer undergoing abiraterone therapy

enthalten in: BJU international | 2017

von Heck, M. | Thaler, M. | Schmid, S. | +11

CommentIn: BJU Int. 2017 Jan;119(1):3-4. - PMID 28000989

2

A 2-Gene Panel Derived From Prostate Cancer-Enhanced Transcripts in Whole Blood Is Prognostic for Survival and Predicts Treatment Benefit in Metastatic Castration-Resistant Prostate Cancer

enthalten in: The Prostate | 2016

von Heck, M. | Thalgott, M. | Schmid, S. | +10

3

Enzalutamide Antitumour Activity Against Metastatic Castration-resistant Prostate Cancer Previously Treated with Docetaxel and Abiraterone : A Multicentre Analysis

enthalten in: European urology | 2015

von Brasso, K. | Thomsen, F. | Schrader, A. | +7

4

Is there an anti-androgen withdrawal syndrome for enzalutamide?

enthalten in: World journal of urology | 2014

von von Klot, C. | Kramer, M. | Böker, A. | +19

1
[1]